In a follow-up on the Candida auris situation in the United States, the Center for Disease Control and Prevention (CDC) put the case tally at 112 as of July 31.

A strain of C. auris cultured in a petri dish at CDC.
A strain of C. auris cultured
in a petri dish at CDC.

The combined cases of New York and New Jersey accounts for 100 of the cases.

Candida auris is an emerging fungus that presents a serious global health threat. Healthcare facilities in several countries have reported that C. auris has caused severe illness in hospitalized patients. Some strains of C. auris are resistant to all three major classes of antifungal drugs. This type of multidrug resistance has not been seen before in other species of Candida.

It was first described in 2009 after being isolated from external ear discharge of a patient in Japan. Since the 2009 report, C. auris infections, specifically fungemia, have been reported from South Korea, India, South Africa, and Kuwait. Although published reports are not available, C. auris has also been identified in Colombia, Venezuela, Pakistan, and the United Kingdom.


Candida map